H19 silencing reversed glioma cell growth and metastasis by regulating the miR-342-mediated Wnt5a/β-Catenin signaling pathway with decreased levels of vascular endothelial growth factor A (VEGFA), MMP9, Wnt5a, and β-catenin (Zhou et al., 2020). Here, VEGFA is linked to central nervous system cancer.